Novo Nordisk's Sustainable Value Creation

Primary tabs

Novo Nordisk's Sustainable Value Creation

Sustainable value creation is a core business strategy focused on addressing fundamental societal issues that provide community benefit, are scalable and generate returns on – and beyond – a profit-and-loss sheet.

Content from this campaign

New Study: 1.5 Billion Dollars Could be Saved by Reducing Complications for People with Diabetes in Russia
April 9, 2015 /3BL Media/ - The challenge of diabetes continues to grow in Russia where 4 million people are diagnosed and even more are unaware of their condition. A new case study shows how Novo Nordisk together with partners is addressing this challenge and outlines the future potential for reducing the social and economic impact of...
Apr 9, 2015 10:00 AM ET
Clinical Trials: More than safety and efficacy
January 27, 2015 /3BL Media/ – Clinical trials are a crucial part of the development process for human medicines. Without clinical trials pharmaceutical companies would be unable to document the efficacy, safety and optimal use of new medicines, limiting access to improved treatments. Developing innovative products that address unmet needs in the treatment of diabetes...
Jan 27, 2015 11:00 AM ET
Novo Nordisk Case Study Shows Path to Lowering Costs and Improving Diabetes Care in Turkey
November 26, 2014 /3BL Media/- More than half of the 7.2 million people living with diabetes in Turkey have a complication[1] that worsens health and are costly to treat. In 2012, treating complications accounted for 74% of total diabetes expenditures. According to the latest estimates from the International Diabetes Federation, by...
Nov 26, 2014 10:00 AM ET
Five Sustainability Stories Not to be Missed!
December 18, 2013 /3BL Media/ - There is still time remaining in 2013 to read the past year’s top sustainability news stories. Here is a recap on the most popular sustainability reads from Novo Nordisk: Novo Nordisk and the Ministry of Health Launch the Blueprint for Change Case on Diabetes in Indonesia In September, Novo Nordisk and the Indonesian...
Dec 18, 2013 10:30 AM ET
Novo Nordisk and the Ministry of Health Launch the Blueprint for Change Case on Diabetes in Indonesia
Jakarta, Indonesia, September 6, 2013 /3BL Media/ - On 3 September, Novo Nordisk and the Indonesian Ministry of Health launched a joint platform to guide efforts to address the rising prevalence of diabetes and its associated costs. The platform is built on the findings from Novo Nordisk’s...
Sep 6, 2013 9:00 AM ET